G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 124 filers reported holding G1 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $214,295 | -74.5% | 39,465 | -41.4% | 0.01% | -80.0% |
| Q3 2022 | $840,000 | +833.3% | 67,293 | +270.3% | 0.03% | +650.0% |
| Q2 2022 | $90,000 | -70.7% | 18,171 | +6.5% | 0.00% | -87.9% |
| Q4 2020 | $307,000 | -65.8% | 17,055 | -78.0% | 0.03% | -43.1% |
| Q3 2020 | $897,000 | +311.5% | 77,670 | +713.5% | 0.06% | +205.3% |
| Q3 2019 | $218,000 | +13.0% | 9,548 | -5.0% | 0.02% | +58.3% |
| Q4 2018 | $193,000 | -72.3% | 10,054 | -24.5% | 0.01% | -76.9% |
| Q3 2018 | $696,000 | – | 13,308 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |